drugset / Trial / NCT01000051
Eltrombopag for Post Transplant Thrombocytopenia
RandomizedSingle-groupTriple-blindTreatment
Summary
The goal of this clinical research study is to learn if eltrombopag can help to improve platelet counts in patients with low platelets after they have had a stem cell transplant. The safety of this drug will also be studied.
Timeline
- Start
- 2010-02-17
- Primary completion
- 2018-04-04
- Completion
- 2018-04-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eltrombopag | Small molecule | 25 mg | Oral |
| Subject | Eltrombopag | Small molecule | 50 mg | Oral |